Research methodological issues in evaluating herbal interventions

References

• Mills S. Herbal medicine. In: Lewith GT, Jonas WB, Walach H, editors. Clinical Research in Complementary Therapies: Principles, Problems and Solutions. Elsevier Science: 2003. p. 211–227.
   Google Scholar
• Lai SL. Clinical Trials of Traditional Chinese Materia Medica. Chapter 1. Guangdong: People’s Publishing House. 2000.
   Google Scholar
• Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States – prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246–252.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. 2004. Guidance for Industry: Botanical drug products.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070491.pdf
   Google Scholar
• Chabot P. The evaluation of holistic care. Intern Rev Comm Dev. 1990; 24:109–114.
   Google Scholar
• Linde K, Jonas WB, Melchart D, Willich S. The methodological Quality of randomised controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol. 2001;30:526–531.
   PubMed Web of Science ®Google Scholar
• Bower H. Double standards exist in judging traditional and alternative medicine. BMJ. 1998;316:1694.
   Google Scholar
• Linde K, Berner M, Egger M, Mulrow C. St. John’s wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry. 2005; 186:99–107.
   PubMed Web of Science ®Google Scholar
• Jonas WB, Linde K. . Conducting and Evaluating Clinical Research on Complementary and Alternative Medicine. In: Gallin JI, editor. Principles and Practice of Clinical Research. San Diego, CA: Academic Press; 2002. p. 401–426.
   Google Scholar
• World Health Organization. Operational guidance: Information needed to support clinical trials of herbal products. 2005. (document reference who /TDR/GEN/Guidance/05.1).
   Google Scholar
• Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group. Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol 2006;59:1134–1149.
   PubMed Web of Science ®Google Scholar
• Spencer JW, Jacobs JJ. Complementary and Alternative Medicine: An Evidence-Based Approach. Elsevier Science; 2003.
   Google Scholar
• May BH, Lit M, Xue CC, et al. Herbal medicine for dementia: a systematic review. Phytother Res. 2009;23:447–459.
   Web of Science ®Google Scholar
• Chen X, Zhou M, Li Q, et al. Sanchi for acute ischaemic stroke. Cochrane Database Syst Rev. 2008;4:CD006305.
   Web of Science ®Google Scholar
• Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol. 1999;55: 567–575.
   PubMed Web of Science ®Google Scholar
• Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136:42–53.
   PubMed Web of Science ®Google Scholar
• Leung PC. Complementary Medicine. In: Machin D, Day S, Green S, editors. Textbook of Clinical Trials. First edition. Chichester: John Wiley & Sons. 2004:63–84.
   Google Scholar
• Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine. JAMA. 1998;280:1585–1589.
   PubMed Web of Science ®Google Scholar
• Wiegant FAC, Kramers CW, van Wijik R. Clinical research in complementary medicine: the importance of patient selection. Complement Med Res. 1991;5:110–115.
   Google Scholar
• Leung PC. Editorial – Seminar series on evidence-based alternative medicine. Hong Kong Med J. 2001;7:332–334.
   Google Scholar
• Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88:251–258.
   PubMed Web of Science ®Google Scholar
• Ernst E, Siev-Ner I, Gamus D. Complementary medicine: a critical review. Israel J Med Sci. 1997;33:808–815.
   Google Scholar
• Zhang ZN, Liu EK, Zheng TL, Li DG. Treatment of chronic myelocytic leukemia (CML) by traditional Chinese medicine and western medicine alternately. J Tradit Chin Med. 1985;5:246–248.
   PubMedGoogle Scholar
• Kirsch I. How Expectancies Shape Experience. 1st Ed. Washington DC: American Psychological Association; 1999.
   Google Scholar
• Moerman DE, Jonas WB. Toward a research agenda on placebo. Adv Mind Body Med. 2000;16:33–46.
   PubMedGoogle Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:1215–1218.
   PubMed Web of Science ®Google Scholar
• Richardson J. The use of randomized control trials in complementary therapies: exploring the Issues. J Adv Nurs. 2000;32:398–406.
   PubMed Web of Science ®Google Scholar
• Porkert M. The theoretical foundations of Chinese medicine – systems of correspondence. Cambridge: MIT Press, MA; 1974.
   Google Scholar
• Gim GT, Kim HM, Kim J, Kim J, Whang WW, Cho SH. Antioxidant effect of tianwang buxin pills a traditional Chinese medicine formula: double-blind, randomized controlled trial. Am J Chin Med. 2009;37:227–239.
   PubMed Web of Science ®Google Scholar
• Ozgoli G, Selselei EA, Mojab F, Majd HA. A randomized, placebo-controlled trial of Ginkgo biloba in treatment of premenstrual syndrome. J Altern Complement Med. 2009;15:845–851.
   PubMed Web of Science ®Google Scholar
• Kelly-Pieper K, Patil SP, Busse P, et al. Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase I study. J Altern Complement Med. 2009;15:735–743.
   Web of Science ®Google Scholar
• Brewin CR, Bradley C. Patient preferences and randomized clinical trials. BMJ. 1989;299:313–315.
   PubMed Web of Science ®Google Scholar
• Zelen M. A new design for randomised clinical trials. N Engl J Med. 1979;300:1242–1245.
   PubMed Web of Science ®Google Scholar
• Critchley JA, Zhang Y, Suthisisang CC, Chan TY, Tomlinson B. Alternative therapies and medical science: designing clinical trials of alternative/complementary medicines-Is evidence-based traditional Chinese medicine attainable? J Clin Pharmacol. 2000;40 462–467.
   Web of Science ®Google Scholar
• Aickin M. Beyond randomization. J Altern Complement Med. 2002; 8:765–772.
   Web of Science ®Google Scholar
• Walker LG, Anderson J. Testing Complementary and Alternative Therapies within a Research Protocol. Eur J Cancer. 1999;35:1614–1618.
   PubMed Web of Science ®Google Scholar
• Buchanan DR, White JD, O’Mara AM, Kelaghan JW, Smith WB, Minasian LM. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine:lessons from the national cancer institute community clinical oncology program. J Clin Oncol. 2005;23:6682–6689.
   PubMed Web of Science ®Google Scholar
• Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study. Phytother Res. 1997;11:508–511.
   Web of Science ®Google Scholar
• Sheehan MP, Rustin MH, Atherton DJ, et al. Efficacy of Chinese herbal therapy in adult atopic dermatitis. Lancet. 1992;340:13–17.
   PubMed Web of Science ®Google Scholar
• Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread nonexudative atopic eczema. Br J Dermatol. 1992;126:179–184.
   PubMed Web of Science ®Google Scholar
• Sheehan MP, Atherton DJ. One year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol. 1994;130:488–493.
   PubMed Web of Science ®Google Scholar
• Bian ZX, Li YP, Moher D, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part i: clinical trial design and methodology. J Chin Integr Med. 2006;4:120–129.
   PubMedGoogle Scholar
• Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group. Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT Statement. Ann Intern Med. 2006;144(5):364–367.
   Web of Science ®Google Scholar
• Schulz KF, Grimes DA. Sample size calculations in randomized trials: mandatory and mystical. Lancet. 2005;365:1348–1353.
   PubMed Web of Science ®Google Scholar
• Howard KL, Orlinsky DE, Perilstein J. Contribution of therapist’s to patient’s experiences in psychotherapy: a components of variance model for analyzing process data. J Consult Clin Psychol. 1976;44: 520–526.
   Web of Science ®Google Scholar
• Mason S, Tovey P, Long AF. Evaluating complementary medicine: methodological challenges of randomised controlled trials. BMJ. 2002;325:832–834.
   PubMed Web of Science ®Google Scholar
• Schnyer RN, Allen JJB. Bridging the gap in complementary and alternative medicine research: manualization as a means of promoting standardization and flexibility of treatment in clinical trials of acupuncture. J Alternat Complement Med. 2002;8:623–634.
   PubMed Web of Science ®Google Scholar
• Sale JEM, Lohfeld LH, Brazil K. Revisiting the quantitative-qualitative debate: implications for mixed-methods research quality and quantity. Quality and Quantity. 2002;36:43–53.
   PubMed Web of Science ®Google Scholar
• Coates JA, Jobst KA. Integrated healthcare: a way forward for the next five years? J Alternat Complement Med. 1998;4:209–27.
   PubMed Web of Science ®Google Scholar
• Vickers A. Complementary medicine. BMJ. 2000;321:683–691.
   PubMed Web of Science ®Google Scholar